Follow
Tod M
Tod M
Faculty of Pharmacy, University Lyon 1, France
Verified email at univ-lyon1.fr
Title
Cited by
Cited by
Year
Facilitation of drug evaluation in children by population methods and modelling
M Tod, V Jullien, G Pons
Clinical pharmacokinetics 47, 231-243, 2008
2142008
Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients
B Blanchet, V Jullien, C Vinsonneau, M Tod
Clinical pharmacokinetics 47, 635-654, 2008
1782008
A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy
B Ribba, G Kaloshi, M Peyre, D Ricard, V Calvez, M Tod, ...
Clinical Cancer Research 18 (18), 5071-5080, 2012
1732012
Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice
B Blanchet, B Billemont, J Cramard, AS Benichou, S Chhun, L Harcouet, ...
Journal of pharmaceutical and biomedical analysis 49 (4), 1109-1114, 2009
1512009
Azithromycin for COVID-19: more than just an antimicrobial?
N Bleyzac, S Goutelle, L Bourguignon, M Tod
Clinical drug investigation 40, 683-686, 2020
1412020
Pharmacokinetic–pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema
F Audren, M Tod, P Massin, R Benosman, B Haouchine, A Erginay, ...
Investigative ophthalmology & visual science 45 (10), 3435-3441, 2004
1402004
Aminoglycosides
O Lortholary, M Tod, O Petitjean, Y Cohen
Medical Clinics of North America 79 (4), 761-787, 1995
1401995
Clinical pharmacokinetics of diacerein
P Nicolas, M Tod, C Padoin, O Petitjean
Clinical pharmacokinetics 35, 347-359, 1998
1301998
Microbiologic epidemiology depending on time to occurrence of prosthetic joint infection: a prospective cohort study
C Triffault-Fillit, T Ferry, F Laurent, P Pradat, C Dupieux, A Conrad, ...
Clinical Microbiology and Infection 25 (3), 353-358, 2019
1282019
Salvage debridement, antibiotics and implant retention (“DAIR”) with local injection of a selected cocktail of bacteriophages: is it an option for an elderly patient with …
T Ferry, G Leboucher, C Fevre, Y Herry, A Conrad, J Josse, C Batailler, ...
Open Forum Infectious Diseases 5 (11), ofy269, 2018
1192018
Variability of sorafenib toxicity and exposure over time: a pharmacokinetic/pharmacodynamic analysis
P Boudou-Rouquette, S Ropert, O Mir, R Coriat, B Billemont, M Tod, ...
The oncologist 17 (9), 1204-1212, 2012
1142012
Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary study
P Boudou-Rouquette, C Narjoz, JL Golmard, A Thomas-Schoemann, ...
Public Library of Science 7 (8), e42875, 2012
1132012
Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders.
G Andreu, A Leon, F Heshmati, M Tod, CJ Menkes, J Baudelot, L Laroche
Transfusion science 15 (4), 443-454, 1994
1051994
Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia
O Lortholary, A Lefort, M Tod, AM Chomat, C Darras-Joly, C Cordonnier
The Lancet infectious diseases 8 (10), 612-620, 2008
1042008
Pharmacokinetics of oral acyclovir in neonates and in infants: a population analysis
M Tod, F Lokiec, R Bidault, F De Bony, O Petitjean, Y Aujard, ...
Antimicrobial agents and chemotherapy 45 (1), 150-157, 2001
962001
Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of …
T Ferry, F Boucher, C Fevre, T Perpoint, J Chateau, C Petitjean, J Josse, ...
Journal of Antimicrobial Chemotherapy 73 (10), 2901-2903, 2018
922018
Population pharmacokinetic study of teicoplanin in severely neutropenic patients
O Lortholary, M Tod, N Rizzo, C Padoin, O Biard, P Casassus, L Guillevin, ...
Antimicrobial agents and chemotherapy 40 (5), 1242-1247, 1996
881996
Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients
O Mimoz, V Binter, A Jacolot, A Edouard, M Tod, O Petitjean, K Samii
Intensive care medicine 24, 1047-1051, 1998
801998
Understanding polyspecificity within the substrate‐binding cavity of the human multidrug resistance P‐glycoprotein
L Martinez, O Arnaud, E Henin, H Tao, V Chaptal, R Doshi, T Andrieu, ...
The FEBS journal 281 (3), 673-682, 2014
772014
Development and validation of an HPLC-UV-visible method for sunitinib quantification in human plasma
B Blanchet, C Saboureau, AS Benichou, B Billemont, F Taieb, S Ropert, ...
Clinica Chimica Acta 404 (2), 134-139, 2009
752009
The system can't perform the operation now. Try again later.
Articles 1–20